ABCL logo

AbCellera Biologics Inc. (ABCL) EBIT

annual EBIT:

-$301.15M-$78.09M(-35.01%)
December 31, 2024

Summary

  • As of today (August 29, 2025), ABCL annual earnings before interest & taxes is -$301.15 million, with the most recent change of -$78.09 million (-35.01%) on December 31, 2024.
  • During the last 3 years, ABCL annual EBIT has fallen by -$523.04 million (-235.71%).
  • ABCL annual EBIT is now -232.63% below its all-time high of $227.06 million, reached on December 31, 2022.

Performance

ABCL EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLincome statement metrics

quarterly EBIT:

-$49.59M+$13.07M(+20.87%)
June 1, 2025

Summary

  • As of today (August 29, 2025), ABCL quarterly earnings before interest & taxes is -$49.59 million, with the most recent change of +$13.07 million (+20.87%) on June 1, 2025.
  • Over the past year, ABCL quarterly EBIT has increased by +$43.87 million (+46.94%).
  • ABCL quarterly EBIT is now -118.39% below its all-time high of $269.59 million, reached on March 31, 2022.

Performance

ABCL quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLincome statement metrics

TTM EBIT:

-$278.66M+$43.87M(+13.60%)
June 1, 2025

Summary

  • As of today (August 29, 2025), ABCL TTM earnings before interest & taxes is -$278.66 million, with the most recent change of +$43.87 million (+13.60%) on June 1, 2025.
  • Over the past year, ABCL TTM EBIT has dropped by -$9.37 million (-3.48%).
  • ABCL TTM EBIT is now -165.94% below its all-time high of $422.62 million, reached on September 30, 2022.

Performance

ABCL TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

ABCL EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-35.0%+46.9%-3.5%
3 y3 years-235.7%-1456.3%-181.5%
5 y5 years-10000.0%-1566.3%-9264.6%

ABCL EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-232.6%at low-194.0%+47.1%-165.9%+13.6%
5 y5-year-232.6%at low-118.4%+47.1%-165.9%+13.6%
alltimeall time-232.6%at low-118.4%+47.1%-165.9%+13.6%

ABCL EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
-$49.59M(-20.9%)
-$278.66M(-13.6%)
Mar 2025
-
-$62.66M(-13.9%)
-$322.53M(+2.5%)
Dec 2024
-$301.15M(+35.0%)
-$72.75M(-22.3%)
-$314.77M(+2.2%)
Sep 2024
-
-$93.66M(+0.2%)
-$308.06M(+14.4%)
Jun 2024
-
-$93.45M(+70.2%)
-$269.29M(+18.5%)
Mar 2024
-
-$54.89M(-16.9%)
-$227.23M(-4.2%)
Dec 2023
-$223.05M(-198.2%)
-$66.05M(+20.3%)
-$237.21M(+14.4%)
Sep 2023
-
-$54.89M(+6.8%)
-$207.38M(+108.0%)
Jun 2023
-
-$51.39M(-20.8%)
-$99.72M(+93.6%)
Mar 2023
-
-$64.87M(+79.1%)
-$51.51M(-118.2%)
Dec 2022
$227.06M(+2.3%)
-$36.22M(-168.6%)
$282.95M(-33.0%)
Sep 2022
-
$52.77M(-1756.3%)
$422.62M(+23.7%)
Jun 2022
-
-$3.19M(-101.2%)
$341.75M(+0.1%)
Mar 2022
-
$269.59M(+160.6%)
$341.51M(+36.6%)
Dec 2021
$221.90M
$103.45M(-468.2%)
$250.01M(-25.3%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$28.10M(+720.8%)
$334.48M(-7.3%)
Jun 2021
-
-$3.42M(-101.9%)
$360.81M(-0.1%)
Mar 2021
-
$178.08M(-5.2%)
$361.26M(+97.2%)
Dec 2020
$164.34M(-8309.0%)
$187.92M(<-9900.0%)
$183.17M(-3961.7%)
Sep 2020
-
-$1.77M(-40.6%)
-$4.74M(+59.4%)
Jun 2020
-
-$2.98M(<-9900.0%)
-$2.98M(<-9900.0%)
Mar 2020
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2019
-$2.00M(-484.3%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2019
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2019
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2019
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2018
$521.00K
-
-
Dec 2018
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2018
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2018
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2018
-
$0.00
$0.00

FAQ

  • What is AbCellera Biologics Inc. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. annual EBIT year-on-year change?
  • What is AbCellera Biologics Inc. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. quarterly EBIT year-on-year change?
  • What is AbCellera Biologics Inc. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. TTM EBIT year-on-year change?

What is AbCellera Biologics Inc. annual earnings before interest & taxes?

The current annual EBIT of ABCL is -$301.15M

What is the all time high annual EBIT for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high annual earnings before interest & taxes is $227.06M

What is AbCellera Biologics Inc. annual EBIT year-on-year change?

Over the past year, ABCL annual earnings before interest & taxes has changed by -$78.09M (-35.01%)

What is AbCellera Biologics Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of ABCL is -$49.59M

What is the all time high quarterly EBIT for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high quarterly earnings before interest & taxes is $269.59M

What is AbCellera Biologics Inc. quarterly EBIT year-on-year change?

Over the past year, ABCL quarterly earnings before interest & taxes has changed by +$43.87M (+46.94%)

What is AbCellera Biologics Inc. TTM earnings before interest & taxes?

The current TTM EBIT of ABCL is -$278.66M

What is the all time high TTM EBIT for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high TTM earnings before interest & taxes is $422.62M

What is AbCellera Biologics Inc. TTM EBIT year-on-year change?

Over the past year, ABCL TTM earnings before interest & taxes has changed by -$9.37M (-3.48%)
On this page